date:Jul 12, 2012
act on the supply of ImmuCyst. Health Canada will continue to consult with its international regulatory counterparts, including the U.S. Food and Drug Administration.
In Canada, the safe use of health products is a responsibility shared among a number of parties, including Health Canada as the regulator that reviews and monitors the safety and efficacy of products, the manufacturers that make them, physicians who prescribe them, and informed consumers. To this end, Health Canada is working with